Company Filing History:
Years Active: 2000-2001
Title: Gordon J Rafool: Innovator in Antiretroviral Research
Introduction
Gordon J Rafool is a notable inventor based in Winter Haven, FL (US). He has made significant contributions to the field of antiretroviral research, holding 2 patents that focus on innovative compositions and methods for inhibiting reverse transcriptase in retroviruses.
Latest Patents
Rafool's latest patents include a composition and method for inhibiting reverse transcript of a retrovirus. This antiretroviral composition utilizes a nucleoside analog containing a six-carbon levo hexose sugar, such as L-rhamnose or L-fucose. The treatment is designed to deliver the antiretroviral to the infected system, effectively inhibiting the reverse transcription process through steric hindrance, thereby halting viral RNA replication. Delivery methods may include conventional approaches like oral dosing or injection, as well as advanced techniques such as packaging in liposomes and protein targeting. Additionally, this composition is beneficial for inhibiting the proliferation of cancer cells by stopping the transcription process.
Another patent by Rafool focuses on a levo-monosaccharide in a nucleoside analog for use as an anti-retroviral. Similar to his previous work, this composition aims to inhibit reverse transcriptase and is delivered through various methods to ensure effective treatment.
Career Highlights
Gordon J Rafool is associated with Promelas Research Corporation, where he continues to advance his research in the field of antiretroviral therapies. His work has the potential to impact the treatment of retroviral infections and cancer.
Collaborations
Rafool collaborates with notable colleagues, including Timothy N Tillman and Daryl Thompson, who contribute to his research endeavors.
Conclusion
Gordon J Rafool's innovative work in antiretroviral research showcases his commitment to developing effective treatments for retroviral infections and cancer. His contributions are significant in the ongoing fight against these diseases.